prikaz prve stranice dokumenta Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola
Access restricted to students and staff of home institution
undergraduate thesis
Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola
Zagreb: University of Zagreb, Faculty of Food Technology and Biotechnology, 2011. urn:nbn:hr:159:412003
Buterin, Ana
University of Zagreb
Faculty of Food Technology and Biotechnology
Department of Food Quality Control
Laboratory for Food Chemistry and Biochemistry

Institutional repository: Repository of the Faculty of Food Technology and Biotechnology

Cite this document

Buterin, A. (2011). Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola (Undergraduate thesis). Zagreb: University of Zagreb, Faculty of Food Technology and Biotechnology. Retrieved from https://urn.nsk.hr/urn:nbn:hr:159:412003

Buterin, Ana. "Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola." Undergraduate thesis, University of Zagreb, Faculty of Food Technology and Biotechnology, 2011. https://urn.nsk.hr/urn:nbn:hr:159:412003

Buterin, Ana. "Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola." Undergraduate thesis, University of Zagreb, Faculty of Food Technology and Biotechnology, 2011. https://urn.nsk.hr/urn:nbn:hr:159:412003

Buterin, A. (2011). 'Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola', Undergraduate thesis, University of Zagreb, Faculty of Food Technology and Biotechnology, accessed 28 May 2024, https://urn.nsk.hr/urn:nbn:hr:159:412003

Buterin A. Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola [Undergraduate thesis]. Zagreb: University of Zagreb, Faculty of Food Technology and Biotechnology; 2011 [cited 2024 May 28] Available at: https://urn.nsk.hr/urn:nbn:hr:159:412003

A. Buterin, "Inhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola", Undergraduate thesis, University of Zagreb, Faculty of Food Technology and Biotechnology, Zagreb, 2011. Available at: https://urn.nsk.hr/urn:nbn:hr:159:412003

Metadata
TitleInhibitori HMG-CoA reduktaze (statini) u prevenciji povišenog kolesterola
Title (english)Inhibitors of HMG-CoA reductase (statins) in the prevention of high cholesterol
AuthorAna Buterin
MentorIrena Landeka Jurčević (mentor)
GranterUniversity of Zagreb
Faculty of Food Technology and Biotechnology
(Department of Food Quality Control)
(Laboratory for Food Chemistry and Biochemistry)
Zagreb
Defense date and country2011-09-15, Croatia
Scientific / art field,
discipline and subdiscipline		BIOTECHNICAL SCIENCES
Nutrition
Abstract
Pravilna se prehrana već odavno povezuje smanjenjem rizika od kardiovaskularnih bolesti izazvanih aterosklerozom. Tijekom posljednjih se desetljeća povećalo zanimanje za takve učinke hrane i u literaturi se danas može naći niz podataka o sastojcima različitih namirnica i pića, kao i epidemiološki podaci o njihovim mogućim učincima. Iako je općeprihvačena opravdanost davanja inhibitora HMG-CoA reduktaze (statina) radi smanjenja ukupnog i LDL-kolesterola u serumu bolesnika s koronarnom bolešču srca (KBS) i onih koji zbog hiperlipidemije imaju povečani rizik, donedavno nije bilo tako jasno treba li statine davati i osobama s manje izraženim rizikom. Rezultati novijih velikih kliničkih ispitivanja i gotovo dva desetlječa kliničkih iskustava sa statinima pokazuju da su oni vrlo djelotvorni u smanjenju rizika za KBS i u primarnoj i u sekundarnoj prevenciji. Iako su se pristupi istraživanjima mijenjali tijekom godina, cilj im je uvijek bio isti – pronaći one najpogodnije te one doze u kojima bi njihova djelotvornost bila najučinkovitija, a rizik od mogućih posljedica najmanji.
Abstract (english)
Healthy nutrition has been long associated with a lower risk of cardiovascular diseases (CVD) due to atherosclerosis, and particularly coronary heart disease and myocardial infarction. Over the last decades the interest for these effects of food has increased, and the literature today provides a series of data about ingredients of various foodstuffs and beverages, as well as epidemiological data on their possible effects. Although treatment with HMG-CoA reductase inhibitors (statins) to reduce total and LDL cholesterol is clearly indicated in patients with coronary heart disease (CHD) and those with increased risk due to hyperlipidemia, the requirements of patients with lower risk were until recently less straightforward. The results of recent large clinical trials with statins and almost two decades of clinical experience have shown that statins are effective and well tolerated in reducing CHD risk for both primary and secondary prevention. Even though the research approaches have changed through the years, the aim has always been the same; to find the most adequate and most effective dosage with the lowest side effect risk.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:159:412003
Study programmeTitle: Nutrition
Study programme type: university
Study level: undergraduate
Academic / professional title: sveučilišni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) nutricionizma (sveučilišni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) nutricionizma)
Type of resourceText
File originBorn digital
Access conditionsAccess restricted to students and staff of home institution
Terms of useLicence In copyright icon
Created on2017-05-18 09:57:37